To further explore the effect of IL1B on spreading HIV-1 infection, stimulated PBMC from five participants were treated with IL1B prior to, at the same time, or after infection with HIV-1 NL4-3 or the transmitted founder CH058 molecular clone. Here, IL1B is linked to HIV-1 infection.